Roche
Roche’s RoActemra recommended for approval
November 26, 2008Sales and Marketing RA, Roche
European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …
Roche strikes deal over Tarceva price
November 17, 2008Sales and Marketing Roche, Taxotere
NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …
Study boost for Roche’s Actemra
October 30, 2008Research and Development, Sales and Marketing RA, Roche
New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
Roche dips on Tamiflu decline
October 24, 2008Sales and Marketing Roche
Roche's sales dropped 2% to 33.3 billion Swiss francs in the first nine months of 2008, due to a sharp …
GlycArt’s new cancer candidate to be developed with Roche
October 9, 2008Research and Development, Sales and Marketing GlycArt, Roche
Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …
Meda acquires four Roche products
August 28, 2008Sales and Marketing Roche
Stockholm-based specialty pharma company Meda has bought four of Roche’s pharma products in a deal worth 120 million Euros – …
Latest news from Datamonitor
July 28, 2008Sales and Marketing Genentech, Roche
Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
